IL10 and colitis: Two routes of administration were also evaluated: the oral route for therapy in the Dinitrobenzene Sulfonic Acid (DNBS)-induced colitis model by administration of recombinant L. lactis SICE:IL-10 and the intranasal route applied to a model of vaccination against HPV-16-induced tumors.